D

Dhg Pharmaceutical Joint-Stock Co
VN:DHG

Watchlist Manager
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Watchlist
Price: 100 000 VND Market Closed
Market Cap: 13.1T VND
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

DHG Price Targets Summary
Dhg Pharmaceutical Joint-Stock Co

Wall Street analysts forecast DHG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DHG is 111 959.62 VND with a low forecast of 102 010 VND and a high forecast of 122 422.65 VND.

DHG Lowest Forecast
Wall Street Target
102 010 VND
2% Upside
DHG Average Forecast
Wall Street Target
111 959.62 VND
12% Upside
DHG Highest Forecast
Wall Street Target
122 422.65 VND
22% Upside
Lowest
Price Target
102 010 VND
2% Upside
Average
Price Target
111 959.62 VND
12% Upside
Highest
Price Target
122 422.65 VND
22% Upside
Dhg Pharmaceutical Joint-Stock Co Competitors:
Price Targets
S
4507
Shionogi & Co Ltd
16% Upside
S
SBBC
Simply Better Brands Corp
88% Upside
4506
Sumitomo Pharma Co Ltd
14% Downside
A
APPH
Apontis Pharma AG
26% Upside
S
4507
Shionogi & Co Ltd
16% Upside
S
SBBC
Simply Better Brands Corp
88% Upside
4506
Sumitomo Pharma Co Ltd
14% Downside
A
APPH
Apontis Pharma AG
26% Upside
600216
Zhejiang Medicine Co Ltd
36% Upside
S
SDZ
Sandoz Group AG
19% Upside
NUVB
Nuvation Bio Inc
360% Upside

Revenue
Forecast

Revenue Estimate
Dhg Pharmaceutical Joint-Stock Co

For the last 9 years the compound annual growth rate for Dhg Pharmaceutical Joint-Stock Co's revenue is 3%. The projected CAGR for the next 2 years is 7%.

3%
Past Growth
7%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Dhg Pharmaceutical Joint-Stock Co

For the last 9 years the compound annual growth rate for Dhg Pharmaceutical Joint-Stock Co's operating income is 3%. The projected CAGR for the next 2 years is 12%.

3%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-11%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Dhg Pharmaceutical Joint-Stock Co

For the last 9 years the compound annual growth rate for Dhg Pharmaceutical Joint-Stock Co's net income is 5%. The projected CAGR for the next 2 years is 10%.

5%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

See Also

Summary
DHG intrinsic value, competitors valuation, and company profile.
DCF Valuation
DHG stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DHG stock valuation using valuation multiples.
Wall Street Estimates
DHG price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DHG stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DHG's stock price target?
Price Target
111 959.62 VND

According to Wall Street analysts, the average 1-year price target for DHG is 111 959.62 VND with a low forecast of 102 010 VND and a high forecast of 122 422.65 VND.

What is Dhg Pharmaceutical Joint-Stock Co's Revenue forecast?
Projected CAGR
7%

For the last 9 years the compound annual growth rate for Dhg Pharmaceutical Joint-Stock Co's revenue is 3%. The projected CAGR for the next 2 years is 7%.

What is Dhg Pharmaceutical Joint-Stock Co's Operating Income forecast?
Projected CAGR
12%

For the last 9 years the compound annual growth rate for Dhg Pharmaceutical Joint-Stock Co's operating income is 3%. The projected CAGR for the next 2 years is 12%.

What is Dhg Pharmaceutical Joint-Stock Co's Net Income forecast?
Projected CAGR
10%

For the last 9 years the compound annual growth rate for Dhg Pharmaceutical Joint-Stock Co's net income is 5%. The projected CAGR for the next 2 years is 10%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 242,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.